VRAX Virax Biolabs Group Limited
$1.19▲ +0.00%
Healthcare
Other
After hours
$1.15▼ -3.36%
Oct 27, 4:33 PM ET
Volume 11.9K
Avg Volume (10D) 28.6K
Key Metrics & Fundamentals
Market Cap
$1.60M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.14 - 21.75
% vs 50 MA
-48.18%
% vs 200 MA
-70.36%
RSI-14
20.6
MACD Histogram
-0.0300
Beta (1Y vs SPY)
2.16
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Top Premarket Decliners
MT Newswires · Oct 9, 2026 7:40 AM ET
Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution
ACCESS Newswire · Aug 20, 2026 10:00 AM ET
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Aug 7, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.